NewAmsterdam Pharma (NAMS) Current Leases (2021 - 2026)
NewAmsterdam Pharma (NAMS) reported Current Leases of $23000.0 for Q1 2026, down 90.87% on a YoY basis from $252000.0 in Q1 2025, and down 83.09% sequentially from $136000.0 in Q4 2025.
NewAmsterdam Pharma (NAMS) Current Leases (2021 - 2026) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 6 years of Current Leases data on file, last reported at $23000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 90.87% year-over-year to $23000.0; the trailing twelve-month figure through Mar 2026 stood at $23000.0 (down 90.87% YoY), and the FY2025 full-year result was $136000.0, down 44.72% from the prior year.
- Current Leases eased to $23000.0 in Q1 2026, from $136000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $252000.0 in Q1 2025 to a low of $23000.0 in Q1 2026.
- A 5-year average of $154841.4 and a median of $181000.0 in 2025 frame the typical range for Current Leases.
- Across the five-year window, Current Leases jumped 486.05% in 2025 and tumbled 90.87% in 2026, its largest moves.
- Tracing NAMS's Current Leases over 5 years: stood at $63255.3 in 2022, then slipped by 5.15% to $60000.0 in 2023, then soared by 310.0% to $246000.0 in 2024, then slumped by 44.72% to $136000.0 in 2025, then slumped by 83.09% to $23000.0 in 2026.
- Business Quant data shows NAMS's Current Leases at $23000.0 in Q1 2026, $136000.0 in Q4 2025, and $181000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | NewAmsterdam Pharma | 3.64 Bn | 3.64 Bn | - | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 136,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 252,000.00 |
| Dec 31, 2024 | 246,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Jun 30, 2024 | 234,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 60,000.00 |
| Dec 31, 2022 | 63,255.34 |
| Dec 31, 2021 | 60,630.46 |